Hepatitis C is curable, with a new class of drugs boasting success rates of 90 percent or more. But the costs of these treatments can pose serious cost issues for state Medicaid programs and other health plans, notes Pavel Lavitas, PharmD, BCPS.
UMass Medical School will bestow the inaugural Warren J. Ferguson Scholarship award to Precious Bedell, a tireless advocate for improving the lives of people affected by incarceration, at the Academic & Health Policy Conference on Correctional Health.
Amid constant change in the world of medicine and health care, insurance adjusters must keep a close eye on the latest advances, notes David Nowell, PhD.
The new crop of hepatitis C drugs released over the past few years are both highly effective and highly expensive, says Pavel Lavitas.
A UMass Medical School health policy expert will share our deep long-term services and supports (LTSS) expertise when presenting at The World Congress 3rd Annual Managed Long Term Services and Supports Summit.
UMass Medical School pharmacists will display some of our pivotal opioid management work and present a NASH budget impact model at the American Drug Utilization Review Society (ADURS) conference February 22-24, 2018 in Scottsdale, Arizona.
Well-trained claims adjusters can play a key role in evaluating valid work-related injuries while also protecting against fraud, says David Nowell, PhD.
The Southern New England Practice Transformation Network (SNE-PTN), a collaborative led by UMass Medical School and UConn Health, has been selected by the Centers for Medicare and Medicaid Services (CMS) to present its cost savings achievements at the 2018 CMS Quality Conference.
Looking closely at cases where treatment failed as well as where it has worked is crucial for running a successful Hepatitis C medication management program, notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
Kenneth Peterson and Working Group on Underrepresented Minorities in Academic Medicine recognized by chancellor; students given MLK Semester of Service awards.
A new crop of drugs has turned Hepatitis C into a curable condition, but getting patients to adhere to intensive drug regimens can sometimes be a challenge, notes Pavel Lavitas, PharmD, BCPS, of UMass Medical School.
To be successful at disability evaluations, public agencies must have access to reviewers with clinical expertise, quality assurance and knowledge of complex federal and state regulations, notes Peter C. Lindblad, MD, medical director UMass Medical School’s Disability Evaluation Services.
The 11th Academic & Health Policy Conference on Correctional Health is now accepting registrations and has announced Josiah D. Rich, MD, MPH, a leading authority in the intersect of infectious disease, addiction treatment and justice-involved individuals, will be the plenary speaker.
A UMass Medical School pharmacy team grew concerned after reviewing the prescriptions of a teen diagnosed with multiple psychiatric disorders, and with a history of bodily harm.